285 related articles for article (PubMed ID: 16612405)
1. Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.
Grabher C; von Boehmer H; Look AT
Nat Rev Cancer; 2006 May; 6(5):347-59. PubMed ID: 16612405
[TBL] [Abstract][Full Text] [Related]
2. Kick it up a Notch: NOTCH1 activation in T-ALL.
Gridley T
Cancer Cell; 2004 Nov; 6(5):431-2. PubMed ID: 15542425
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture.
Chiaramonte R; Calzavara E; Balordi F; Sabbadini M; Capello D; Gaidano G; Serra A; Comi P; Sherbet GV
J Cell Biochem; 2003 Feb; 88(3):569-77. PubMed ID: 12532332
[TBL] [Abstract][Full Text] [Related]
4. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
[TBL] [Abstract][Full Text] [Related]
5. NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.
Zhu YM; Zhao WL; Fu JF; Shi JY; Pan Q; Hu J; Gao XD; Chen B; Li JM; Xiong SM; Gu LJ; Tang JY; Liang H; Jiang H; Xue YQ; Shen ZX; Chen Z; Chen SJ
Clin Cancer Res; 2006 May; 12(10):3043-9. PubMed ID: 16707600
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling induces SKP2 expression and promotes reduction of p27Kip1 in T-cell acute lymphoblastic leukemia cell lines.
Dohda T; Maljukova A; Liu L; Heyman M; Grandér D; Brodin D; Sangfelt O; Lendahl U
Exp Cell Res; 2007 Aug; 313(14):3141-52. PubMed ID: 17560996
[TBL] [Abstract][Full Text] [Related]
7. Notch in T-ALL: new players in a complex disease.
Koch U; Radtke F
Trends Immunol; 2011 Sep; 32(9):434-42. PubMed ID: 21775206
[TBL] [Abstract][Full Text] [Related]
8. NOTCH and PI3K-AKT pathways intertwined.
Gutierrez A; Look AT
Cancer Cell; 2007 Nov; 12(5):411-3. PubMed ID: 17996644
[TBL] [Abstract][Full Text] [Related]
9. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
11. Targeting promiscuous signaling pathways in cancer: another Notch in the bedpost.
Beverly LJ; Capobianco AJ
Trends Mol Med; 2004 Dec; 10(12):591-8. PubMed ID: 15567329
[TBL] [Abstract][Full Text] [Related]
12. NOTCH1-induced T-cell leukemia in transgenic zebrafish.
Chen J; Jette C; Kanki JP; Aster JC; Look AT; Griffin JD
Leukemia; 2007 Mar; 21(3):462-71. PubMed ID: 17252014
[TBL] [Abstract][Full Text] [Related]
13. Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53.
Mungamuri SK; Yang X; Thor AD; Somasundaram K
Cancer Res; 2006 May; 66(9):4715-24. PubMed ID: 16651424
[TBL] [Abstract][Full Text] [Related]
14. [Functional analysis of notch in the pathophysiology of leukemia].
Tohda S
Rinsho Byori; 2009 Apr; 57(4):351-6. PubMed ID: 19489437
[TBL] [Abstract][Full Text] [Related]
15. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
16. Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia.
Vilimas T; Mascarenhas J; Palomero T; Mandal M; Buonamici S; Meng F; Thompson B; Spaulding C; Macaroun S; Alegre ML; Kee BL; Ferrando A; Miele L; Aifantis I
Nat Med; 2007 Jan; 13(1):70-7. PubMed ID: 17173050
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 receptor beta chain locus rearrangement in a T-cell acute lymphoblastic leukemia.
Berger R; Bernard OA
Pathol Biol (Paris); 2007 Feb; 55(1):56-8. PubMed ID: 16697123
[TBL] [Abstract][Full Text] [Related]
18. Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.
Fiorini E; Merck E; Wilson A; Ferrero I; Jiang W; Koch U; Auderset F; Laurenti E; Tacchini-Cottier F; Pierres M; Radtke F; Luther SA; Macdonald HR
J Immunol; 2009 Dec; 183(11):7212-22. PubMed ID: 19915064
[TBL] [Abstract][Full Text] [Related]
19. Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice.
Mizuno T; Yamasaki N; Miyazaki K; Tazaki T; Koller R; Oda H; Honda ZI; Ochi M; Wolff L; Honda H
Oncogene; 2008 May; 27(24):3465-74. PubMed ID: 18193087
[TBL] [Abstract][Full Text] [Related]
20. T cell acute lymphoblastic leukemia: NOTCHing the way toward a better treatment outcome.
Pui CH
Cancer Cell; 2009 Feb; 15(2):85-7. PubMed ID: 19185842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
